Friday 21 Feb, 2020 08:28 AM
Site map | Locate Us | Login
   Total vehicle registration fall 7% in January: FADA    Axis Bank to explore long-term strategic partnership with Max Life     J&K Bank surges nearly 15% in three days    Oil India Ltd leads losers in 'A' group    Atishay Ltd leads losers in 'B' group    Volumes soar at Max Financial Services Ltd counter    Future Lifestyle board approves fund raising    Consumer Durables stocks ease    Real Estate shares slide    Energy stocks edge lower    Jammu and Kashmir Bank Ltd spikes nearly 10%    Cadila Healthcare Ltd up for third straight session    Glenmark Pharmaceuticals Ltd in demand     APL Apollo Tubes Ltd spurts 1.77%    Inox Leisure Ltd rises for third consecutive session 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
Biocon rises on buzz investors eye stake in subsidiary
21-Aug-19   14:19 Hrs IST

According to reports, Singapore's investment company Temasek and private equity fund True North along with Canadian Pension Plan Investment Board (CPPIB) are separately in discussions to invest $300 million in Biocon Biologics India (BBIL) for a minority stake. BBIL is a wholly owned subsidiary of Biocon.

Reports added that BBIL may be valued upwards of $4 billion (Rs 28,000 crore), which is higher than Biocon's current market cap of Rs 26,664 crore.

On a consolidated basis, Biocon's net profit rose 72.3% to Rs 206.30 crore on a 30.4% increase in net sales to Rs 1465.90 crore in Q1 June 2019 over Q1 June 2018.

On the BSE, 2.12 lakh shares were traded in the Biocon counter so far compared with average daily volumes of 2.09 lakh shares in the past two weeks. The scrip has underperformed the market in past one year, down 27.74% as against Sensex's 2.48% fall.

Biocon is a fully integrated, innovation-led global bio-pharmaceuticals company.

Powered by Capital Market - Live News

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.G Anand , anand@ssplwealth.com
Hit Count : 13698775
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016  |  MCX : INZ000081736
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 12815 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. Saravana Stocks Pvt. Ltd